Pfizer briefs NJ public on Superfund site cleanup

Pfizer ($PFE) is all for spreading the word about its cleanup of a contaminated New Jersey site inherited through its acquisition of Wyeth. The drug giant is conducting a PR campaign to inform the public about environmental problems at the American Cyanamid Superfund site and to describe the feasibility studies it ran to prepare a cleanup plan.

The Somerset Messenger-Gazette reports Pfizer produced a 22-minute video that helps translate the project for nonprofessionals. Company representatives were slated to show the video and answer questions about the feasibility studies during two public meetings.

The 435-acre chemical manufacturing site operated from 1915 to 1999, the report said. It made the Environmental Protection Agency's Superfund site list in 1983.

Neither Pfizer nor Wyeth had any role in the contamination, according to the report. Pfizer worked with federal and state officials to develop 8 candidate remediation plans. The EPA is expected later this month to name which of the 8 will be implemented.

- here's the story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.